Lung Diseases, Obstructive  >>  AZD 2423  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD 2423 / AstraZeneca
NCT01215279 / 2010-020891-43: AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD)

Completed
2a
63
Europe
AZD2423, Placebo to AZD2423
AstraZeneca
Chronic Obstructive Pulmonary Disease, Lung Disease
03/11
03/11
NCT01153321 / 2010-020141-26: Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD)

Completed
2a
71
Europe
AZD2423, AZD2423 Placebo
AstraZeneca
Chronic Obstructive Pulmonary Disease, Lung Disease
07/11
07/11

Download Options